PHARMA SIGNALOPEN RESEARCH PLATFORM →
CLINICAL TRIAL PROFILE · UPDATED 2026-09-29

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

NCT06672549 · Phase 3 · Recruiting

PHASEPhase 3
STATUSRecruiting
ENROLLMENT125
EST. COMPLETION2027-02

Conditions

ObesityOverweight

Interventions

OrforglipronPlacebo

Study details

SPONSOREli Lilly and Company
START DATE2024-11-18

Related company profiles

Eli Lilly

LLY

Primary source

Trial status and dates can change. Confirm enrollment and eligibility against the linked ClinicalTrials.gov record.

Evidence & limits

Source: Open the source record

Record identifier
NCT06672549
Event / action date
Not separately retained
Source update date
Not separately retained
Platform retrieval / processing date
Not separately retained

What it supports. Study information reported by the sponsor or investigator, including status, phase, enrollment, and recorded dates.

Limits. Registration or completion does not establish clinical success or approval. Sponsor-name associations can be ambiguous. Dates may be estimated; verify the live study record.

Connection basis. Company sponsor aliases and normalized lead-sponsor containment; the NCT identifier identifies the study.

What this record means · Report an issue with this record